David Patience insider trades
Open-market stock purchases and sales by David Patience, Chief Financial Officer at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Apr 1, 2023.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +5%.